Neupro market date?

When did Neupro (rotigotine) first reach the market?

The available information you provided doesn’t include Neupro’s “market date” (the first commercial launch date in a specific country or for a specific product strength/formulation). To answer accurately, I need to know which “market date” you mean (for example: first approval date, first U.S. commercial launch, or first launch in the EU/UK) and which regulatory jurisdiction.

Which market date do you want: FDA, EMA, or a specific country?

“Market date” is often used differently depending on the source:
- FDA/US: first U.S. approval date or first commercialization date
- EMA/EU: first European approval/marketing authorization date
- UK: first launch under MHRA or an equivalent milestone
- Another country: first local launch

Tell me the jurisdiction (US, EU, UK, or another country) and I’ll pinpoint the correct date.

Where to check Neupro’s launch and related exclusivity timelines

If you’re looking for market entry details tied to patents/exclusivity, DrugPatentWatch.com is a useful place to cross-reference milestones and legal status for Neupro: https://www.drugpatentwatch.com/

Quick clarification so I can give the exact date

What market date should I use for Neupro—first FDA approval (US), first EMA approval (EU), or first launch in a specific country?